| 1. |
- Jones, Geraint H., et al.
(författare)
-
The Comet Interceptor Mission
- 2024
-
Ingår i: Space Science Reviews. - : Springer Nature. - 0038-6308 .- 1572-9672. ; 220:1
-
Tidskriftsartikel (refereegranskat)abstract
- Here we describe the novel, multi-point Comet Interceptor mission. It is dedicated to the exploration of a little-processed long-period comet, possibly entering the inner Solar System for the first time, or to encounter an interstellar object originating at another star. The objectives of the mission are to address the following questions: What are the surface composition, shape, morphology, and structure of the target object? What is the composition of the gas and dust in the coma, its connection to the nucleus, and the nature of its interaction with the solar wind? The mission was proposed to the European Space Agency in 2018, and formally adopted by the agency in June 2022, for launch in 2029 together with the Ariel mission. Comet Interceptor will take advantage of the opportunity presented by ESA’s F-Class call for fast, flexible, low-cost missions to which it was proposed. The call required a launch to a halo orbit around the Sun-Earth L2 point. The mission can take advantage of this placement to wait for the discovery of a suitable comet reachable with its minimum Δ V capability of 600 ms − 1 . Comet Interceptor will be unique in encountering and studying, at a nominal closest approach distance of 1000 km, a comet that represents a near-pristine sample of material from the formation of the Solar System. It will also add a capability that no previous cometary mission has had, which is to deploy two sub-probes – B1, provided by the Japanese space agency, JAXA, and B2 – that will follow different trajectories through the coma. While the main probe passes at a nominal 1000 km distance, probes B1 and B2 will follow different chords through the coma at distances of 850 km and 400 km, respectively. The result will be unique, simultaneous, spatially resolved information of the 3-dimensional properties of the target comet and its interaction with the space environment. We present the mission’s science background leading to these objectives, as well as an overview of the scientific instruments, mission design, and schedule.
|
|
| 2. |
- Klamt, Tobias, et al.
(författare)
-
Flexible Disaster Response of Tomorrow: Final Presentation and Evaluation of the CENTAURO System
- 2019
-
Ingår i: IEEE robotics & automation magazine. - : IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC. - 1070-9932 .- 1558-223X. ; 26:4, s. 59-72
-
Tidskriftsartikel (refereegranskat)abstract
- Mobile manipulation robots have great potential for roles in support of rescuers on disaster-response missions. Robots can operate in places too dangerous for humans and therefore can assist in accomplishing hazardous tasks while their human operators work at a safe distance. We developed a disaster-response system that consists of the highly flexible Centauro robot and suitable control interfaces, including an immersive telepresence suit and support-operator controls offering different levels of autonomy.
|
|
| 3. |
- Attié, David, et al.
(författare)
-
A time projection chamber with GEM-based readout
- 2017
-
Ingår i: Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. - : Elsevier BV. - 0168-9002. ; 856, s. 109-118
-
Tidskriftsartikel (refereegranskat)abstract
- For the International Large Detector concept at the planned International Linear Collider, the use of time projection chambers (TPC) with micro-pattern gas detector readout as the main tracking detector is investigated. In this paper, results from a prototype TPC, placed in a 1. T solenoidal field and read out with three independent Gas Electron Multiplier (GEM) based readout modules, are reported. The TPC was exposed to a 6. GeV electron beam at the DESY II synchrotron. The efficiency for reconstructing hits, the measurement of the drift velocity, the space point resolution and the control of field inhomogeneities are presented.
|
|
| 4. |
- Behnke, Gregor, et al.
(författare)
-
On Partial Satisfaction Planning with Total-Order HTNs
- 2023
-
Ingår i: Proceedings of the 33rd International Conference on Automated Planning and Scheduling (ICAPS 2023). ; , s. 42-51
-
Konferensbidrag (refereegranskat)abstract
- Since its introduction, partial satisfaction planning (PSP), including both oversubscription (OSP) and net-benefit, has received significant attention in the classical planning community. However, hierarchical aspects have been mostly ignored in this context, although several problem domains that form the main motivation for PSP, such as the rover domain, have an inherent hierarchical structure. In this paper, we are taking the necessary steps for facilitating this research direction. First, we formally define hierarchical partial satisfaction planning problems and discuss the usefulness and necessity of this formalism. Second, we present a carefully structured set of benchmarks consisting of OSP and net-benefit problems with hierarchical structure. We describe and analyze the different domains of the benchmark set and the desiderata that are met to provide an interesting and challenging starting point for upcoming research. Third, we introduce various planning techniques that can solve hierarchical OSP problems and investigate their empirical behaviour on our proposed benchmark.
|
|
| 5. |
- Behnke, Michael, et al.
(författare)
-
Information technology aspects of large-scale implementation of automated surveillance of healthcare-associated infections
- 2021
-
Ingår i: Clinical Microbiology and Infection. - : Elsevier. - 1198-743X .- 1469-0691. ; 27:Suppl 1, s. S29-S39
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: Healthcare-associated infections (HAI) are a major public health concern. Monitoring of HAI rates, with feedback, is a core component of infection prevention and control programmes. Digitalization of healthcare data has created novel opportunities for automating the HAI surveillance process to varying degrees. However, methods are not standardized and vary widely between different healthcare facilities. Most current automated surveillance (AS) systems have been confined to local settings, and practical guidance on how to implement large-scale AS is needed. Methods: This document was written by a task force formed in March 2019 within the PRAISE network (Providing a Roadmap for Automated Infection Surveillance in Europe), gathering experts in HAI surveillance from ten European countries. Results: The document provides an overview of the key e-health aspects of implementing an AS system of HAI in a clinical environment to support both the infection prevention and control team and information technology (IT) departments. The focus is on understanding the basic principles of storage and structure of healthcare data, as well as the general organization of IT infrastructure in surveillance networks and participating healthcare facilities. The fundamentals of data standardization, interoperability and algorithms in relation to HAI surveillance are covered. Finally, technical aspects and practical examples of accessing, storing and sharing healthcare data within a HAI surveillance network, as well as maintenance and quality control of such a system, are discussed. Conclusions: With the guidance given in this document, along with the PRAISE roadmap and governance documents, readers will find comprehensive support to implement large-scale AS in a surveillance network.
|
|
| 6. |
- Devos, David, et al.
(författare)
-
Trial of Deferiprone in Parkinson’s Disease
- 2022
-
Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 387:22, s. 2045-2055
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUNDIron content is increased in the substantia nigra of persons with Parkinson's disease and may contribute to the pathophysiology of the disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson's disease, but its effects on disease progression are unclear.METHODSWe conducted a multicenter, phase 2, randomized, double-blind trial involving participants with newly diagnosed Parkinson's disease who had never received levodopa. Participants were assigned (in a 1:1 ratio) to receive oral deferiprone at a dose of 15 mg per kilogram of body weight twice daily or matched placebo for 36 weeks. Dopaminergic therapy was withheld unless deemed necessary for symptom control. The primary outcome was the change in the total score on the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS; range, 0 to 260, with higher scores indicating more severe impairment) at 36 weeks. Secondary and exploratory clinical outcomes at up to 40 weeks included measures of motor and nonmotor disability. Brain iron content measured with the use of magnetic resonance imaging was also an exploratory outcome.RESULTSA total of 372 participants were enrolled; 186 were assigned to receive deferiprone and 186 to receive placebo. Progression of symptoms led to the initiation of dopaminergic therapy in 22.0% of the participants in the deferiprone group and 2.7% of those in the placebo group. The mean MDS-UPDRS total score at baseline was 34.3 in the deferiprone group and 33.2 in the placebo group and increased (worsened) by 15.6 points and 6.3 points, respectively (difference, 9.3 points; 95% confidence interval, 6.3 to 12.2; P<0.001). Nigrostriatal iron content decreased more in the deferiprone group than in the placebo group. The main serious adverse events with deferiprone were agranulocytosis in 2 participants and neutropenia in 3 participants.CONCLUSIONSIn participants with early Parkinson's disease who had never received levodopa and in whom treatment with dopaminergic medications was not planned, deferiprone was associated with worse scores in measures of parkinsonism than those with placebo over a period of 36 weeks.
|
|
| 7. |
- Hansmann, Georg, et al.
(författare)
-
2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
- 2019
-
Ingår i: The Journal of Heart and Lung Transplantation. - : Elsevier BV. - 1053-2498. ; 38:9, s. 879-901
-
Forskningsöversikt (refereegranskat)abstract
- © 2019 The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit organization that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of pediatric pulmonary hypertensive vascular disease, including pulmonary hypertension (PH) associated with bronchopulmonary dysplasia, PH associated with congenital heart disease (CHD), persistent PH of the newborn, and related cardiac dysfunction. The executive writing group members conducted searches of the PubMed/MEDLINE bibliographic database (1990–2018) and held face-to-face and web-based meetings. Ten section task forces voted on the updated recommendations, based on the 2016 executive summary. Clinical trials, meta-analyses, guidelines, and other articles that include pediatric data were searched using the term “pulmonary hypertension” and other keywords. Class of recommendation (COR) and level of evidence (LOE) were assigned based on European Society of Cardiology/American Heart Association definitions and on pediatric data only, or on adult studies that included >10% children or studies that enrolled adults with CHD. New definitions by the World Symposium on Pulmonary Hypertension 2018 were included. We generated 10 tables with graded recommendations (COR/LOE). The topics include diagnosis/monitoring, genetics/biomarkers, cardiac catheterization, echocardiography, cardiac magnetic resonance/chest computed tomography, associated forms of PH, intensive care unit/lung transplantation, and treatment of pediatric PH. For the first time, a set of specific recommendations on the management of PH in middle- and low-income regions was developed. Taken together, these executive, up-to-date guidelines provide a specific, comprehensive, detailed but practical framework for the optimal clinical care of children and young adults with PH.
|
|
| 8. |
- Karopka, Thomas, et al.
(författare)
-
Minimum data set and standards in the context of nosocomial infection surveillance and antimicrobial stewardship
- 2016
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- Antimicrobial resistance (AMR), i.e., the ability of microbes such as bacteria, viruses, fungi and parasites to resist the actions of one or more antimicrobial drugs or agents, is a serious global threat. Bacterial antibiotic resistance poses the largest threat to public health. The prevention of antimicrobial infections and their spread relies heavily on infection control management, and requires urgent, coordinated action by many stakeholders. This is especially true for nosocomial infections, also known as healthcare-associated infections (HAIs), i.e., infections that are acquired in healthcare settings. It is known that continuous, systematic collection, analysis and interpretation of data relevant to nosocomial infections and feedback for the use by doctors and nurses can reduce the frequency of these infections. Data from one hospital are more valid and more effective when they are compared with those from other hospitals. In order to avoid false conclusions, comparisons are only possible when identical methods of data collection with fixed diagnostic definitions are used. The automatic aggregation of standardized data using data from electronic medical records (EMRs), lab data, surveillance data and data on antibiotic use would greatly enhance comparison and computerized decision support systems (CDSSs). Once standardized, data can be aggregated from unit to institutional, regional, national and EU level, analysed and fed back to enhance local decision support on antibiotic use and detection of nosocomial infections.
|
|
| 9. |
- McMahon, Colin J, et al.
(författare)
-
Adult congenital heart disease training in Europe: current status, disparities and potential solutions.
- 2023
-
Ingår i: Open heart. - 2053-3624. ; 10:2
-
Tidskriftsartikel (refereegranskat)abstract
- This study aimed to determine the status of training of adult congenital heart disease (ACHD) cardiologists in Europe.A questionnaire was sent to ACHD cardiologists from 34 European countries.Representatives from 31 of 34 countries (91%) responded. ACHD cardiology was recognised by the respective ministry of Health in two countries (7%) as a subspecialty. Two countries (7%) have formally recognised ACHD training programmes, 15 (48%) have informal (neither accredited nor certified) training and 14 (45%) have very limited or no programme. Twenty-five countries (81%) described training ACHD doctors 'on the job'. The median number of ACHD centres per country was 4 (range 0-28), median number of ACHD surgical centres was 3 (0-26) and the median number of ACHD training centres was 2 (range 0-28). An established exit examination in ACHD was conducted in only one country (3%) and formal certification provided by two countries (7%). ACHD cardiologist number versus gross domestic product Pearson correlation coefficient=0.789 (p<0.001).Formal or accredited training in ACHD is rare among European countries. Many countries have very limited or no training and resort to 'train people on the job'. Few countries provide either an exit examination or certification. Efforts to harmonise training and establish standards in exit examination and certification may improve training and consequently promote the alignment of high-quality patient care.
|
|
| 10. |
- Taitler, Ayal, et al.
(författare)
-
The 2023 International Planning Competition
- 2024
-
Ingår i: The AI Magazine. - : AMER ASSOC ARTIFICIAL INTELL. - 0738-4602.
-
Tidskriftsartikel (refereegranskat)abstract
- In this article, we present an overview of the 2023 International Planning Competition. It featured five distinct tracks designed to assess cutting-edge methods and explore the frontiers of planning within these settings: the classical (deterministic) track, the numeric track, the Hierarchical Task Networks (HTN) track, the learning track, and the probabilistic and reinforcement learning track. Each of these tracks evaluated planning methodologies through one or more subtracks, with the goal of pushing the boundaries of current planner performance. To achieve this objective, the competition introduced a combination of well-established challenges and entirely novel ones. Within this article, each track offers an exploration of its historical context, justifies its relevance within the planning landscape, discusses emerging domains and trends, elucidates the evaluation methodology, and ultimately presents the results.
|
|
